Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Post by NorthSunon Nov 10, 2020 1:35pm
169 Views
Post# 31871155

How Biden could benefit Aphria

How Biden could benefit Aphria

In addition to spending heavily on clean energy and infrastructure, the Biden campaign has promised to decriminalize marijuana at the federal level. It would be an important step toward full-fledged legalization in the U.S., and it could make it easier for cannabis companies to gain greater access to banking and other much-needed services. It might also help to improve Americans' views toward cannabis, perhaps accelerating legalization at the state level in the process.

These trends would all be highly beneficial to Aphria (NASDAQ: APHA). Aphria is one of the more profitable cannabis companies, with six straight quarters of positive adjusted earnings before interest, taxes, depreciation, and appreciation (EBITDA). It's also flush with cash; Aphria ended its most recent quarter with over $400 million in cash reserves.

Better still, Aphria is well-positioned to profit from the growth of the U.S. marijuana market. The cannabis producer recently reached an agreement to acquire Sweetwater Brewing Co., one of the largest independent craft brewers in the U.S. and maker of the popular 420 brand. The deal is expected to strengthen Aphria's retail distribution network in the U.S. ahead of federal legalization of cannabis -- which could come sooner than investors currently expect, should Biden be elected president.
 

<< Previous
Bullboard Posts
Next >>